GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Change In Payables And Accrued Expense

Acepodia (ROCO:6976) Change In Payables And Accrued Expense : NT$0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia Change In Payables And Accrued Expense?

Acepodia's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2024 was NT$0.00 Mil. It means Acepodia's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Jun. 2024 .

Acepodia's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was NT$0.00 Mil. It means Acepodia's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Acepodia Change In Payables And Accrued Expense Historical Data

The historical data trend for Acepodia's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia Change In Payables And Accrued Expense Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
- - - -

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Payables And Accrued Expense Get a 7-Day Free Trial - - - - -

Acepodia Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acepodia Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Acepodia's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Acepodia Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
ROCO:4174 ROCO:6617 ROCO:4162 ROCO:6712 ROCO:4147 ROCO:6586 ROCO:6547 ROCO:6919 TPE:4142 ROCO:4157 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Website
https://www.acepodia.com
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines